ALKBH5 and breast cancer: Subsequently, the overexpressed ALKBH5 demethylates ESPL1 mRNA and decreases the binding between ESPL1 mRNA and IGF2BP3, which facilitates the degradation of ESPL1 and ultimately inhibits the progression of BC (88).